Welcome to our dedicated page for Capital Bancorp SEC filings (Ticker: CBNK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Capital Bancorp, Inc. filings document the regulatory disclosures of a Maryland bank holding company for Capital Bank, N.A. Recent Form 8-K reports cover quarterly and annual financial results, investor presentations, cash dividends, stock repurchase authorization, subordinated note redemption, and other material corporate events.
The company’s proxy and governance filings describe board structure, director elections and appointments, committee assignments, executive compensation, equity awards, and shareholder voting matters. Officer employment agreements and related compensatory arrangements appear in current reports, while capital-structure disclosures address common stock activity and bank holding company financing instruments.
Capital Bancorp (CBNK) reported insider equity activity by President and COO Steven M. Poynot. On 10/11/2025, 666 common shares were acquired via the settlement of restricted stock units (transaction code M) at $0. The same day, 201 shares were disposed of (code F) at $28.76, typically for tax withholding.
Following these transactions, holdings were 1,397 shares direct and 5,253 shares indirect (by IRA). Derivative holdings include 1,131 RSUs and multiple option grants with scheduled vesting per the award terms.
Marc H. McConnell, a director of Capital Bancorp Inc (CBNK), reported multiple equity transactions dated 10/09/2025. He acquired 323 shares at $14.82 and 1,292 shares at $19.18, increasing his direct beneficial ownership to 13,434 shares. He also holds significant indirect positions: 156,926 shares via McConnell Legacy Investments, LLC, 3,345 via an IRA, 44,823 via a revocable trust, plus 557 shares each held indirectly for his son and daughter.
He received multiple stock options and 405 restricted stock units in a merger exchange; the options have various exercise prices and vesting schedules, with exercisability and expiration dates listed through 01/28/2031 and later. The RSU award vests on 03/03/2026. The form is signed by Mr. McConnell (by attorney-in-fact) on 10/10/2025.
Michael Breckheimer, SVP and Head of Windsor Advantage at Capital Bancorp Inc (CBNK), reported insider transactions dated 10/02/2025. He received 23,102 Restricted Stock Units (RSUs) (Code M) that vest on 10/02/2025, recorded at $0, which increased his direct beneficial ownership to 39,548 shares before a sale. On the same date he disposed of 7,127 shares (Code F) at a price of $31.04, leaving him with 32,421 shares beneficially owned. The filing also lists multiple stock option grants received in a merger with specified strike prices and vesting schedules and an additional 600 RSU grant vesting in four annual installments beginning 03/03/2026. The form is signed on 10/03/2025.
Karl Dicker, identified as a director and an officer (EVP and President of OpenSky) of Capital Bancorp, Inc. (CBNK), reported changes in his beneficial ownership on transactions dated 08/29/2025. The filing discloses an acquisition of 6,873 shares of Common Stock at $13.89 and a disposition of 3,592 shares at $34.50, leaving reported beneficial ownership totals of 63,194 and 59,602 shares respectively following each reported transaction. Table II lists outstanding equity derivatives and restricted stock units, including multiple option grants with exercise prices from $13.89 to $30.51 and 1,015 restricted stock units that vest over time as noted in the explanations. The Form 4 is signed by Karl Dicker through an attorney-in-fact.
Capital Bancorp, Inc. (CBNK) filed a Form 144 notifying the proposed sale of 40,000 shares of common stock through Keefe, Bruyette & Woods on NASDAQ, with an aggregate market value of $1,374,906.48 and approximately 16,583,541 shares outstanding. The securities were originally acquired on June 24, 2013 as a purchase of 10,000 shares for $17 per share that later split into 40,000 shares. The filing lists an approximate sale date of August 26, 2025. The filer reports no sales of issuer securities in the past three months and includes the standard attestation that no undisclosed material adverse information is known.
Randall James Levitt reported insider transactions in Capital Bancorp, Inc. (CBNK). On 08/26/2025 he sold 2,662 shares at $34.41 and on 08/27/2025 he sold 37,338 shares at $34.37. The Form 4 lists multiple indirect holdings: 97,338 shares held by Montrose Lending Group, LLC; 266,665 by the Randall James Levitt Revocable Trust; 30,700 by RJL Investment Company, LLC; 154,056 by Maud Associates, LLC; and 452,000 by BTC Trust Company of South Dakota. Reported derivative holdings include stock options totaling 11,681 underlying shares and 811 restricted stock units vesting 03/03/2026. The form is signed by an attorney-in-fact on 08/28/2025.
Capital Bancorp reported stronger core results for the quarter ended June 30, 2025, with growth across loans, deposits and earnings following its IFH acquisition. Total assets reached $3.389 billion, up from $3.207 billion, driven by portfolio loans of $2.748 billion gross and cash and cash equivalents of $274.6 million. Deposits rose to $2.941 billion from $2.762 billion. Net interest income increased to $47.6 million from $37.1 million, and the company recorded quarterly net income of $13.136 million ($0.79 basic EPS) versus $8.205 million a year earlier. Total noninterest income doubled to $13.1 million, partly from government lending and servicing, while noninterest expenses increased to $39.6 million, including merger-related costs. Credit metrics show rising delinquencies and nonaccruals ($36.2 million) and an ACL of $47.4 million. The IFH acquisition added scale with $83.5 million consideration and goodwill of $22.5 million after a $1.4 million measurement adjustment.
Capital Bancorp (CBNK) Form 4: EVP & CFO Dominic C. Canuso bought 600 common shares on 07/31/2025 at $31.11, a cash outlay of roughly $18.7 k. His direct holding rises to 4,834 shares.
The filing lists unexercised equity incentives: 2,000 options at $21.57 (expire 07/15/2029), 1,754 options at $30.51 (expire 03/03/2030), plus 2,773 RSUs that begin vesting between 07/15/2025 and 03/03/2026. Each RSU converts 1-for-1 into common stock; no derivative disposals occurred.
The buy increases Canuso’s stake by about 14% and represents the first reported open-market purchase since his last option grant, potentially signaling executive confidence. However, the dollar value is modest relative to CBNK’s market capitalization and daily volume.